Rob’s Fundamental Stock Analysis

Rob’s Fundamental Stock Analysis

Share this post

Rob’s Fundamental Stock Analysis
Rob’s Fundamental Stock Analysis
$snpx explained

$snpx explained

Rob's Educated Guesses's avatar
Rob's Educated Guesses
May 23, 2022
∙ Paid
2

Share this post

Rob’s Fundamental Stock Analysis
Rob’s Fundamental Stock Analysis
$snpx explained
1
Share

I have gotten a few questions on $SNPX and figured I would take the time to go thru some history to explain the optimism on the 4Q read out.  First, the company failed two phase II trials a couple years back.  Why?  Trial design.  Remember Alzheimer’s has had no approved drugs to reduce the decline of cognitive effects let alone what $SNPX Bryostatin 1 …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Fein Luxe LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share